Index by Author

August 2006; 6 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abernethy, Darrell R.

B

  1. Bohn, Laura

    • How Specific Are “Target-Specific” Drugs? Celecoxib as a Case in Point Mol Interv August 2006 6:196-198; doi:10.1124/mi.6.4.5

C

  1. Carrico, Christie

    • Breaking the Mold: A Lesson in Perseverance Mol Interv August 2006 6:228-229; doi:10.1124/mi.6.4.9

G

  1. Gilroy, Derek W.

J

  1. Jonas, Elizabeth

L

  1. Lucchesi, Benedict R.

R

  1. Rajakariar, Ravindra

  2. Rettie, Allan E.

    • The Pharmocogenomics of Warfarin: Closing in on Personalized Medicine Mol Interv August 2006 6:223-227; doi:10.1124/mi.6.4.8

S

  1. Sadée, Wolfgang

    • How Specific Are “Target-Specific” Drugs? Celecoxib as a Case in Point Mol Interv August 2006 6:196-198; doi:10.1124/mi.6.4.5

  2. Scheindlin, Stanley

    • Rare Diseases, Orphan Drugs, and Orphaned Patients Mol Interv August 2006 6:186-191; doi:10.1124/mi.6.4.2

  3. Stern, Paula H.

    • The Calcineurin-NFAT Pathway and Bone: Intriguing New Findings Mol Interv August 2006 6:193-196; doi:10.1124/mi.6.4.4

T

  1. Tai, Guoying

    • The Pharmocogenomics of Warfarin: Closing in on Personalized Medicine Mol Interv August 2006 6:223-227; doi:10.1124/mi.6.4.8

Y

  1. Yaqoob, Muhammad M.

Current Issue

  1. April 2011, 11 (2)
  1. Current Issue
  1. Alert me to new issues of MI
Society Logo HighWire Press Logo CLOCKSS logo